Related Experiment Video
Updated: May 6, 2026
Author Spotlight: Advancing Cardiac Procedure Testing Prior to Embarking on Large Animal Studies
Published on: August 25, 2023
Using cardiac biomarkers in veterinary practice
1Section of Cardiology, Department of Clinical Studies-Philadelphia, School of Veterinary Medicine, University of Pennsylvania, 3900 Delancey Street, Philadelphia, PA 19104, USA.
Insights
Cardiac biomarker testing aids in diagnosing heart disease in pets. Assays like cardiac troponin-I and N-terminal pro-B-type natriuretic peptide help identify disease and assess patient risk.
Area of Science:
- Veterinary Medicine
- Cardiology
- Biomarker Discovery
Background:
- Cardiac diseases are a significant concern in canine and feline medicine.
- Accurate diagnosis and risk assessment are crucial for effective management of heart conditions in pets.
Purpose of the Study:
- To review the utility of blood-based cardiac biomarker assays in veterinary cardiology.
- To highlight the role of biomarkers in diagnosing heart disease and predicting outcomes in dogs and cats.
Main Methods:
- Review of current scientific literature on cardiac biomarkers in companion animals.
- Focus on cardiac troponin-I and N-terminal pro-B-type natriuretic peptide assays.
- Analysis of biomarker application in differentiating cardiac vs. non-cardiac respiratory disease and detecting preclinical cardiomyopathy.
Main Results:
- Cardiac biomarker assays, specifically cardiac troponin-I and N-terminal pro-B-type natriuretic peptide, are valuable diagnostic tools.
- These tests aid in distinguishing cardiac from non-cardiac causes of respiratory distress.
- Biomarker testing can detect preclinical cardiomyopathy and assess morbidity and mortality risk in animals with heart disease.
Conclusions:
- Cardiac biomarker testing is increasingly important in veterinary clinical practice.
- Effective use requires proper patient selection, accurate result interpretation, and integration with existing diagnostic approaches.
- Biomarker assays enhance the diagnostic capabilities for heart disease in dogs and cats.
Abstract:
Blood-based assays for various cardiac biomarkers can assist in the diagnosis of heart disease in dogs and cats. The two most common markers are cardiac troponin-I and N-terminal pro-B-type natriuretic peptide. Biomarker assays can assist in differentiating cardiac from noncardiac causes of respiratory signs and detection of preclinical cardiomyopathy. Increasingly, studies indicate that cardiac biomarker testing can help assess the risk of morbidity and mortality in animals with heart disease. Usage of cardiac biomarker testing in clinical practice relies on proper patient selection, correct interpretation of test results, and incorporation of biomarker testing into existing diagnostic methods.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...